reviewing all of the state situation on an individual basis. and here s why. and i saw this from my and being in congress where my state things in july that the money is going to be sufficient for risk corridor payments. then they here in october that no, that s not going to happen. and have a real degree of uncertainty without cms is getting that state co-op with them how they re doing their capitalization, how they re feeling they are viability and they don t know day today whether they re going to build to offer a product in open enrollment period that starts on november 1. so the concern that a lot of us have is we don t have some kind of a bright line rule, the uncertainty in those states is really contributing to instability in all insurance market. i assume you understand those points by making. absolutely. so i m hoping that you and your staff would be willing to continue to meet with our committee staff on both sides of the aisle to help us figure out how we can he
and after the court s decision. that is coming up next on t weimar cases on c-span, c-span3, and c-span radio. for more background, order your copy of the landmark cases companion book. it is available for a dollars $.95 plus shipping at c-span.org/landmark cases. here on c-span live at the heritage foundation in washington, d.c. or a discussion with our consent arkansas republican senator tom cotton on disability benefits. joining us on the c-span network, we remind our internet and television viewers that questions and comments can be sent to us at any time by e-mailing speaker at heritage.org. we will post the program on the heritage homepage for future reference. in-house, we do appreciate the courtesy of cell phones being silenced as we prepare to begin. hosting our program and introducing our special guest is ambassador terry miller. our fellow and economic freedom and director of the center for data analysis and trade and economics. he directs all of our ongoing
Local hospitals are bringing FDA-approved Bispecific T-cell Engager therapy to the region. Providers claim it could extend and improve blood cancer patients' quality of life.